The inkjet manufacturer is aiming to raise £15m to fund the move, which will create 200 jobs at the site in Cambridgeshire, more than doubling staff at that location and boosting the firm’s global headcount by 50%.

The company has received valid acceptances for 8,158,762 of the 8,827,345 new ordinary shares that were issued, at 170p per new ordinary share, representing approximately 92.4% of those available.

The remaining 668,583 new ordinary shares, representing 7.6%, have been allocated to the placees with whom they had been conditionally placed.

Xaar has made its application to the UKLA for the new ordinary shares to be admitted to the official list and to the London Stock Exchange for the new ordinary shares to be admitted to trading on the London Stock Exchange's main market for listed securities.

Dealings in the new ordinary shares will commence on 11 November 2010.

Through the expansion, annual production capacity of the firm’s 1001 product will increase to 45,000 units, which will come on stream by the end of 2012. It follows the investment to double production at the site from the current 10,000 units to 20,000 units by the end of 2011.

"We’re starting to see a real transition towards inkjet as it becomes an established production technique," Xaar chief executive Ian Dinwoodie said previously.